Blastocyst Formation Rates in Chromosomally Normal Versus Abnormal Embryos As Analyzed by 24 Chromosome Microarray-Based Anueploidy Screening (Mpgd)

K.A. Miller,X. Li,K. Lambrese,J. Su,N. Treff,R.T. Scott
DOI: https://doi.org/10.1016/j.fertnstert.2008.07.1588
IF: 6.7
2008-01-01
Fertility and Sterility
Abstract:OBJECTIVE: Blastocyst culture and transfer is utilized as a tool to select embryos with higher implantation rates. The addition of mPGD may enhance embryo selection and improve patient outcomes. mPGD was utilized to evaluate the relationship between anueploidy and blastulation rates of embryos in extended culture.DESIGN: Retrospective study of IVF patients undergoing extended culture with embryo biopsy and mPGD.MATERIALS AND METHODS: Oocyte retrieval and ICSI were performed according to standard protocols. Embryos were biopsied on day 3 or 5 of development and ploidy status was determined by 24 chromosome mPGD as previously described. Embryos were classified by mPGD as having a normal or abnormal complement of chromosomes. Abnormal embryos were further classified according to their errors: sex chromosomal, autosomal trisomy, autosomal monosomy or multiple errors. Blastocyst formation rates were compared between groups and statistical analysis was performed using Chi-square tests.Table 1Aneuploidy StatusBlastocyst FormationNormal60% (21/35)Abnormal Sex70.6% (12/17)Trisomy50% (9/18)Monosomy47% (9/19)Multiple21% (6/29) Open table in a new tab CONCLUSIONS: This study evaluating the full karyotype of developing human embryos demonstrates that ploidy status is associated with blastulation. While aneuploid embryos are significantly less likely to blastulate, it is still quite common. This suggests that blastulation rates alone may not be sufficient to fully prognosticate the reproductive potential of an individual embryo. Improvements in embryo selection using blastocyst transfer in tandem with mPGD may increase the possibility of selecting embryos with higher implantation rates. A randomized clinical trial is currently underway. OBJECTIVE: Blastocyst culture and transfer is utilized as a tool to select embryos with higher implantation rates. The addition of mPGD may enhance embryo selection and improve patient outcomes. mPGD was utilized to evaluate the relationship between anueploidy and blastulation rates of embryos in extended culture. DESIGN: Retrospective study of IVF patients undergoing extended culture with embryo biopsy and mPGD. MATERIALS AND METHODS: Oocyte retrieval and ICSI were performed according to standard protocols. Embryos were biopsied on day 3 or 5 of development and ploidy status was determined by 24 chromosome mPGD as previously described. Embryos were classified by mPGD as having a normal or abnormal complement of chromosomes. Abnormal embryos were further classified according to their errors: sex chromosomal, autosomal trisomy, autosomal monosomy or multiple errors. Blastocyst formation rates were compared between groups and statistical analysis was performed using Chi-square tests. CONCLUSIONS: This study evaluating the full karyotype of developing human embryos demonstrates that ploidy status is associated with blastulation. While aneuploid embryos are significantly less likely to blastulate, it is still quite common. This suggests that blastulation rates alone may not be sufficient to fully prognosticate the reproductive potential of an individual embryo. Improvements in embryo selection using blastocyst transfer in tandem with mPGD may increase the possibility of selecting embryos with higher implantation rates. A randomized clinical trial is currently underway.
What problem does this paper attempt to address?